SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-14-075347
Filing Date
2014-12-22
Accepted
2014-12-22 16:21:00
Documents
7
Period of Report
2014-12-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K v396941_8k.htm 8-K 23008
2 EXHIBIT 1.1 v396941_ex1-1.htm EX-1.1 240494
3 EXHIBIT 5.1 v396941_ex5-1.htm EX-5.1 8308
4 EXHIBIT 99.1 v396941_ex99-1.htm EX-99.1 9691
5 EXHIBIT 99.2 v396941_ex99-2.htm EX-99.2 6328
6 GRAPHIC image_001.jpg GRAPHIC 3151
7 GRAPHIC image_002.jpg GRAPHIC 3175
  Complete submission text file 0001144204-14-075347.txt   298232
Mailing Address 21900 BURBANK BLVD. THIRD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. THIRD FLOOR WOODLAND HILLS CA 91367 818-992-3126
Lion Biotechnologies, Inc. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53127 | Film No.: 141303260
SIC: 2836 Biological Products, (No Diagnostic Substances)